Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.

Liang PI, Wang YH, Wu TF, Wu WR, Liao AC, Shen KH, Hsing CH, Shiue YL, Huang HY, Hsu HP, Chen LT, Lin CY, Tai C, Wu JY, Li CF.

J Clin Pathol. 2013 Jul;66(7):573-82. doi: 10.1136/jclinpath-2012-201278.

PMID:
23539739
2.
3.

INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.

Lee HY, Li CC, Huang CN, Li WM, Yeh HC, Ke HL, Yang KF, Liang PI, Li CF, Wu WJ.

J Surg Oncol. 2015 Mar 15;111(4):414-22. doi: 10.1002/jso.23836.

PMID:
25488476
4.

GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.

Chang IW, Lin VC, Hung CH, Wang HP, Lin YY, Wu WJ, Huang CN, Li CC, Li WM, Wu JY, Li CF.

World J Urol. 2015 Nov;33(11):1777-89. doi: 10.1007/s00345-015-1522-7.

PMID:
25813210
5.
6.

Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.

Liang PI, Wu LC, Sheu JJ, Wu TF, Shen KH, Wang YH, Wu WR, Shiue YL, Huang HY, Hsu HP, Chen YH, Chen LT, Li CF, Liao AC.

J Clin Pathol. 2012 Sep;65(9):802-7. doi: 10.1136/jclinpath-2012-200897.

PMID:
22685262
7.

FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.

Fan EW, Li CC, Wu WJ, Huang CN, Li WM, Ke HL, Yeh HC, Wu TF, Liang PI, Ma LJ, Li CF.

J Urol. 2015 Jul;194(1):223-9. doi: 10.1016/j.juro.2015.01.073.

PMID:
25623741
8.

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.

Ma LJ, Wu WJ, Wang YH, Wu TF, Liang PI, Chang IW, He HL, Li CF.

J Cancer. 2016 Jan 29;7(4):467-76. doi: 10.7150/jca.13625.

9.

CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.

Lee YY, Wu WJ, Huang CN, Li CC, Li WM, Yeh BW, Liang PI, Wu TF, Li CF.

J Cancer. 2016 Mar 26;7(6):711-21. doi: 10.7150/jca.14281.

10.

HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.

Chang IW, Liang PI, Li CC, Wu WJ, Huang CN, Lin VC, Hsu CT, He HL, Wu TF, Hung CH, Li CF.

Tumour Biol. 2015 Jul;36(7):5441-50. doi: 10.1007/s13277-015-3210-z.

PMID:
25934334
11.

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.

Li WM, Huang CN, Ke HL, Li CC, Wei YC, Yeh HC, Chang LL, Huang CH, Liang PI, Yeh BW, Chan TC, Li CF, Wu WJ.

Oncotarget. 2016 Oct 21. doi: 10.18632/oncotarget.12795. [Epub ahead of print]

13.

CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.

Chang IW, Lin VC, He HL, Hsu CT, Li CC, Wu WJ, Huang CN, Wu TF, Li CF.

Am J Transl Res. 2015 Apr 15;7(4):710-22.

14.

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder.

Chang IW, Wang YH, Wu WJ, Liang PI, Li WM, Yeh BW, Wu TF, He HL, Huang SK, Li CF.

J Cancer. 2016 Jan 10;7(3):304-13. doi: 10.7150/jca.13638.

15.

Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.

Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, RouprĂȘt M; French Collaborative National Database on U.U.T.-U.C..

BJU Int. 2012 Oct;110(8):1134-41. doi: 10.1111/j.1464-410X.2012.10960.x.

16.

Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.

Li WM, Wei YC, Huang CN, Ke HL, Li CC, Yeh HC, Chang LL, Huang CH, Li CF, Wu WJ.

J Surg Oncol. 2016 May;113(6):700-7. doi: 10.1002/jso.24195.

PMID:
26861489
17.

Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma.

Ke HL, Chang LL, Yang SF, Lin HH, Li CC, Wu DC, Wu WJ.

Urol Oncol. 2011 Nov-Dec;29(6):703-9. doi: 10.1016/j.urolonc.2009.10.009.

PMID:
20022267
18.

Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.

Tanaka N, Kikuchi E, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakamura S, Oya M.

BJU Int. 2013 May;111(6):857-64. doi: 10.1111/j.1464-410X.2012.11353.x.

20.

A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.

Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.

BJU Int. 2012 Dec;110(11 Pt C):E1237-48. doi: 10.1111/j.1464-410X.2012.11569.x.

Items per page

Supplemental Content

Support Center